ClinicalTrials.gg
Not yet recruitingNCT07942610Updated Nov 17, 2026

Audio Hypnotherapy for Preoperative Anxiety and Inflammatory Markers in Elective Cesarean Section

An interventional study of Audio Hypnotherapy in Preoperative Anxiety, Cesarean Section and Inflammation, sponsored by Udayana University. Not yet recruiting at 1 site in Indonesia. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Udayana University · Not applicable, Interventional, and Supportive care

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 34 studies in Inflammation with a site in Indonesia — 9 open to participants now, 9 under way, none of them phase 3. Inflammation · Indonesia.

Planned enrollment
14th of 32
60 · median 60
Started
2026
with 6 others
No phase
21 of 34
8 open now
Registered
34th of 34
by date
Lead sponsor
4 of 34
Udayana University

Among the 34 studies in Inflammation with a site in Indonesia, this one is the 14th largest by planned enrollment of the 32 interventional ones that give a count, is one of 7 that started in 2026, is one of 21 with no phase, and was the 34th registered.

Inflammation

3,543 studies on the registry are indexed under Inflammation; 648 are open to participants now.

Browse Inflammation studies →

Open to participants now

9 of the 34 studies in Inflammation with a site in Indonesia are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →

Who these studies take

Of the 463 Inflammation studies recruiting now, 174 (38%) set no upper age limit and 208 (45%) stop at 75 or younger; 58 take children under 18; 166 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Inflammation with a site in Indonesia, or all of them as a file.
02

Study summary

This randomized controlled trial tests whether listening to an audio hypnotherapy recording before a planned cesarean section reduces preoperative anxiety and changes blood markers of inflammation. Sixty pregnant women scheduled for elective cesarean section under spinal anesthesia at Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia, will be randomly assigned in a 1:1 ratio to receive either two 30-minute audio hypnotherapy sessions (the evening before surgery and the morning of surgery) or standard care without hypnotherapy. Anxiety will be measured with the Amsterdam Preoperative Anxiety and Information Scale (APAIS). NF-kB, IL-6 and IL-10 will be measured in blood before the intervention and 24 hours after surgery.

Read the detailed description

Background: Preoperative anxiety is common in women undergoing cesarean section. Anxiety activates the hypothalamic-pituitary-adrenal (HPA) axis and is associated with activation of nuclear factor-kappa B (NF-kB), increased interleukin-6 (IL-6) and decreased interleukin-10 (IL-10). Premedication drugs used to reduce anxiety can cause allergy and sedation, and their fetal safety is debated. Hypnotherapy is a non-pharmacological option, but its effect on both anxiety and inflammatory markers in cesarean section has not been well studied.

Design: Single-center, parallel-group, randomized controlled trial with pretest-posttest measurement. Participants are allocated 1:1 by a computer-generated random sequence concealed in sequentially numbered, sealed, opaque envelopes prepared by a third party not involved in the study.

Procedures: Eligible patients are screened one day before surgery and sign informed consent. Baseline APAIS score and baseline blood samples for NF-kB, IL-6 and IL-10 are collected. The hypnotherapy group listens to a 30-minute hypnotherapy audio recording in the evening before surgery and again in the morning of surgery. The control group receives standard care without hypnotherapy. APAIS is repeated on the morning of surgery before entering the operating room. All patients receive spinal anesthesia and standard postoperative analgesia according to hospital protocol. Blood samples are repeated 24 hours after surgery. IL-6 and IL-10 are measured by ELISA; NF-kB is measured in peripheral blood lymphocytes.

Sample size: 27 per group based on a previous study (mean anxiety difference 5.76, SD 5.19). Allowing 10% dropout, 30 per group (60 total) will be enrolled.

Analysis: Between-group comparisons by independent t-test or Mann-Whitney U test; within-group pre-post comparisons by paired t-test or Wilcoxon test. P \< 0.05 is considered significant.

03

Conditions studied

  • Preoperative Anxiety
  • Cesarean Section
  • Inflammation

Browse trials for

Keywords

  • Hypnotherapy
  • Hypnosis
  • APAIS
  • NF-kappa B
  • Interleukin-6
  • Interleukin-10
  • Spinal Anesthesia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women scheduled for elective cesarean section at Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali
  • Planned spinal (subarachnoid block) anesthesia
  • Willing to participate and to sign

Exclusion criteria

Exclusion Criteria:

  • Emergency cesarean section
  • Planned general anesthesia
  • Use of narcotic or psychotropic drugs
  • Medical conditions affecting the HPA axis, such as endocrine disorders
  • Need for postoperative intensive care unit admission
  • Unwilling to undergo the hypnotherapy intervention
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Hypnotherapy Group

    Participants listen to a 30-minute pre-recorded audio hypnotherapy session twice: in the evening before surgery and in the morning of surgery, in addition to standard perioperative care.

    Behavioral: Audio Hypnotherapy

  • No intervention
    Control Group

    Participants receive standard perioperative care without hypnotherapy.

Interventions

  • BehavioralAudio Hypnotherapy

    Pre-recorded hypnotherapy audio with induction, deepening, positive suggestions for calmness and a smooth cesarean section, relaxing background music, and termination. Delivered for 30 minutes on two occasions: the evening before surgery and the morning of surgery.

06

What researchers measure

Primary outcomes

  1. Change in Preoperative Anxiety Score (APAIS)

    Anxiety measured with the Indonesian version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anxiety subscale is the sum of items 1, 2, 4 and 5, each scored 1-5 (total 4-20). Higher scores indicate greater anxiety.

    Time frame: Baseline (day before surgery, before the first session) and morning of surgery (after the second session, before entering the operating room)

Secondary outcomes

  1. Change in NF-kB Level

    NF-kB measured in peripheral blood lymphocytes isolated from venous blood.

    Time frame: Baseline (day before surgery) and 24 hours after surgery

  2. Change in Serum IL-6

    Serum interleukin-6 measured by ELISA (ng/L).

    Time frame: Baseline (day before surgery) and 24 hours after surgery

  3. Change in Serum IL-10

    Serum interleukin-10 measured by ELISA (pg/mL).

    Time frame: Baseline (day before surgery) and 24 hours after surgery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because participant consent did not include data sharing. Aggregated results will be published.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

Of 881 non-industry interventional studies with no phase under Inflammation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 1 month is below that.

Counting every sponsor, half of 928 studies reached it within 17 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 17, 2026
StartEst.
Nov 12, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Jan 12, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942610
Lead sponsor
Udayana University
Responsible party
Tjahya Aryasa (Principal Investigator, Anesthesiologist, Udayana University) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 12, 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Jan 12, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Tjahya Aryasa EM, MD
Contact
tjahya_em@unud.ac.id
+6281339713553
Tjahya Aryasa EM, MD
principal investigator · Udayana University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion